Oxford Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Oxford Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$128K	Buy	+10,308	New	+$138K	0.06%	396
2025 Q2	–	Sell	-20,725	Closed	-$174K	–	523
2025 Q1	$174K	Sell	20,725 -34,801	-63%	-$290K	0.08%	376
2024 Q4	$440K	Buy	+55,526	New	+$466K	0.2%	180
2020 Q1	–	Sell	-270,657	Closed	-$1.3M	–	276
2019 Q4	$1.3M	Buy	270,657 +131,945	+95%	+$459K	0.04%	693
2019 Q3	$402K	Buy	+138,712	New	+$484K	0.01%	1346
2019 Q1	–	Sell	-28,792	Closed	-$390K	–	1641
2018 Q4	$390K	Buy	+28,792	New	+$519K	0.01%	1297
2018 Q3	–	Sell	-108,303	Closed	-$1.79M	–	1674
2018 Q2	$1.79M	Buy	+108,303	New	+$1.9M	0.03%	730

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Oxford Asset Management's AMRX Position: Q1 2026 in Review

Oxford Asset Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q1 2026: 10,308 shares worth $128K. The stake represents 0.06% of the portfolio and ranks #396 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in AMRX as recently as Q1 2025.

Oxford Asset Management first reported a position in AMRX in Q2 2018 and has held it in 7 quarters since. The position peaked at $1.79M in Q2 2018. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

Oxford Asset Management held 10,308 shares of Amneal Pharmaceuticals worth $128K as of Q1 2026.
Amneal Pharmaceuticals was a new Oxford Asset Management position in Q1 2026.
Amneal Pharmaceuticals made up 0.06% of Oxford Asset Management's portfolio in Q1 2026, its #396 holding.
Oxford Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 7 quarters since.
Oxford Asset Management's Amneal Pharmaceuticals position peaked at $1.79M in Q2 2018.
315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.